{"success":true,"data":{"_id":475183080,"filings":[{"Organization":{"Hours":[0],"Total Compensation":[0],"Direct compensation":[0],"Other compensation":[0]},"Basic":{"mission":"Advance the availability of safe and effective regenerative cell therapies for patients in need","primary_activities":"1. In support of its goal to advance therapies to support patients in need, the organization convened an advisory committee comprised of scientists, researchers, clinical experts, and patients to guide the development of policy reports, including those summarizing the state of the field, barriers to progress, policy actions needed to advance the field, and the status of federal activities related to regenera- tive medicine and cell therapy. 2. In support of its goal to advance therapies to support patients in need through education and advocacy, the organization developed white papers, briefs, and other communications materials and both hosted and conducted briefings to raise awareness of the current state","year":2022,"name":"Alliance for Cell Therapy Now","phone":"2029229077","website":"www.allianceforcelltherapynow.org","type":"990","principal_officer":"JANET MARCHIBRODA","year_formation":2015,"state_legal_domicile":"DC","tax_period_begin":"2022-01-01T00:00:00","tax_period_end":"2022-12-31T00:00:00","address":"300 New Jersey Avenue NW Ste 900, Washington, DC, 20001, USA","city":"Washington","state":"DC","country":"USA","zip_code":"20001"},"Governance":{"501c determination":true,"Number of voting members":3,"Number of independent voting members":2,"Number of employees total":0,"Total Gross UBI":0,"Number of employees":0,"Prohibited tax shelter transactions":false,"Taxable party notification":false,"Family or business relationship":false,"Delegation of management duties":false,"Conflict of interest policy":true,"Whistle blower policy":true,"Compensation process for CEO":false,"Compensation process for other employees":false,"Changes to organizing documents":false,"Material diversion or misuse":false,"Members or stockholders":false,"Election of board members":false,"Decisions subject to approval":false,"Minutes of governing body":true,"Local chapters":false,"Form 990 provided to governing body":true,"Document retention policy":true,"Investment in joint venture":false,"Independent audit financial statements":false,"Consolidated audit financial statements":false,"Accountant compile or review":false,"Financial statements audited by independent accountant":false,"Federal grant audit required":false,"Political activities":false,"Donor advised funds":false,"Conservation easements":false,"Collections of art":false,"School":false,"Hospital":false,"Foreign activities":false,"Foreign office":false,"Gaming":false,"Fundraising activities":false,"Professional fundraising":false,"Loan to officer or DQP":false,"Grant to related person":false,"Business relationship through family member":false,"Business relationship with organization":true},"Revenues":{"value":350000,"Contributions":{"value":350000,"Other contributions":350000},"Program revenue":{"value":0},"Investment income":{"value":0},"Other revenues":{"value":0,"Net income from fundraising events":0}},"Expenses":{"value":397552,"Grant expense":{"value":0},"Total professional fundraising expense":{"value":0},"Benefits paid to members":{"value":0},"Salaries":{"value":0},"Other expenses":{"value":397552,"Legal":4011,"Accounting":1250,"Other services":361078,"Office expenses":915,"Occupancy":2677,"Travel":4363,"Conferences and meetings":5473,"Insurance":8061,"Itemized Expenses":9724},"Functional Expenses":{"Program Service Expenses":368306,"Management And General Expenses":29246,"Fundraising Expenses":0}},"Assets":{"value":69144,"Non-interest bearing cash":69144},"Liabilities":{"value":49253,"Accounts payable, accrued":49253},"Fund balance":{"value":19891},"Form990Details":{"program_service_accomplishments":[{"description":"1. In support of its goal to advance therapies to support patients in need, the organization convened an advisory committee comprised of scientists, researchers, clinical experts, and patients to guide the development of policy reports, including those summarizing the state of the field, barriers to progress, policy actions needed to advance the field, and the status of federal activities related to regenera- tive medicine and cell therapy. 2. In support of its goal to advance therapies to support patients in need through education and advocacy, the organization developed white papers, briefs, and other communications materials and both hosted and conducted briefings to raise awareness of the current state","expense":368306}],"functional_expense_allocations":{"legal_fees":{"management_and_general":4011,"total":4011},"accounting_fees":{"management_and_general":1250,"total":1250},"other_service_fees":{"program_services":348290,"management_and_general":12788,"total":361078},"office_expenses":{"program_services":456,"management_and_general":459,"total":915},"occupancy":{"total":2677},"travel":{"program_services":4363,"total":4363},"conferences_meetings":{"program_services":5473,"total":5473},"insurance":{"management_and_general":8061,"total":8061}},"tax_and_disclosure_flags":{"activities_conducted_through_partnership":false,"foreign_financial_account":false,"backup_withholding_compliance":true,"lobbying_activities":false,"deductible_non_cash_contributions":false,"deductible_contributions_of_art":false,"donor_restricted_or_quasi_endowments":false,"method_of_accounting_accrual":true,"schedule_o_part_vi":true,"schedule_o_part_ix":true},"principal_officer_detail":{"person_name":"JANET MARCHIBRODA"},"audit_financial_statement_detail":{"accountant_compile_or_review":false,"federal_grant_audit_required":false},"related_party_due_diligence":{"business_relationship_with_35_controlled_entity":true,"officer_mailing_address":false,"related_entity":true,"related_org_controlled_entity":false,"compensation_from_other_sources":false,"excess_benefit_transaction":false,"annual_disclosure_covered_persons":true},"grant_due_diligence":{"grants_to_organizations":false,"grants_to_individuals":false,"more_than_5000_to_organizations":false,"more_than_5000_to_individuals":false},"books_in_care_of_detail":{"phone":"2055334260","business_name_line1":"Crosby Ottenhoff Group","address_line1":"611 PENNSYLVANIA AVE SE Ste 267","city":"Washington","state":"DC","zip":"20003"},"officers_directors_key_employees":[{"person_name":"JOANNE KURTZBERG","title":"DIRECTOR","average_hours_per_week":1.0,"reportable_comp_from_org":0,"reportable_comp_from_related_orgs":0,"other_compensation":0,"individual_trustee_or_director":true,"name":"JOANNE KURTZBERG"},{"person_name":"FRED SANFILIPPO","title":"DIRECTORCHAIRMAN","average_hours_per_week":1.0,"average_hours_per_week_related_org":1.0,"reportable_comp_from_org":0,"reportable_comp_from_related_orgs":0,"other_compensation":0,"individual_trustee_or_director":true,"officer":true,"name":"FRED SANFILIPPO"},{"person_name":"JANET MARCHIBRODA","title":"PRESIDENTSECRETARY","average_hours_per_week":5.0,"average_hours_per_week_related_org":23.0,"reportable_comp_from_org":0,"reportable_comp_from_related_orgs":0,"other_compensation":0,"individual_trustee_or_director":true,"officer":true,"name":"JANET MARCHIBRODA"},{"person_name":"MICHELE REISNER","title":"TREASURER","average_hours_per_week":0.3,"average_hours_per_week_related_org":0.1,"reportable_comp_from_org":0,"reportable_comp_from_related_orgs":0,"other_compensation":0,"officer":true,"name":"MICHELE REISNER"}]},"ScheduleB":{"attached":true,"required":true},"ScheduleL":{"excess_benefit_transactions":[{"transaction_corrected":false},{"transaction_corrected":false},{"transaction_corrected":false},{"transaction_corrected":false},{"transaction_corrected":false},{"transaction_corrected":false}],"loans_between_organization_and_interested_persons":[{"default":false,"approved_by_board":false,"written_agreement":false},{"default":false,"approved_by_board":false,"written_agreement":false},{"default":false,"approved_by_board":false,"written_agreement":false},{"default":false,"approved_by_board":false,"written_agreement":false},{"default":false,"approved_by_board":false,"written_agreement":false},{"default":false,"approved_by_board":false,"written_agreement":false},{"default":false,"approved_by_board":false,"written_agreement":false},{"default":false,"approved_by_board":false,"written_agreement":false},{"default":false,"approved_by_board":false,"written_agreement":false},{"default":false,"approved_by_board":false,"written_agreement":false}],"business_transactions_involving_interested_persons":[{"person_name":"MARCHIBRODA GROUP LLC","relationship":"See PartV below","description":"See PartV below","amount":44000,"sharing_of_revenues":false,"name":"MARCHIBRODA GROUP LLC"},{"sharing_of_revenues":false},{"sharing_of_revenues":false},{"sharing_of_revenues":false},{"sharing_of_revenues":false},{"sharing_of_revenues":false},{"sharing_of_revenues":false},{"sharing_of_revenues":false},{"sharing_of_revenues":false},{"sharing_of_revenues":false}],"supplemental_information":[{"form_and_line_reference":"PART IV # 1","explanation":"The Marchibroda Group, LLC, which is 100% controlled by President Janet"},{"form_and_line_reference":"PART IV # 1","explanation":"Marchibroda, received $44,000 in fees from Alliance for Cell Therapy"},{"form_and_line_reference":"PART IV # 1","explanation":"Now for consulting and management services."}]},"ScheduleR":{"tax_exempt_organizations":[{"ein":861221438,"business_name_line1":"ALLIANCE FOR CELL THERAPY FOUNDATION","primary_activities_text":"Education","exempt_code_section_text":"501 c3","public_charity_status_text":"170b1Avi","controlled_organization_indicator":false,"legal_domicile_state":"DC","address_line1":"300 NEW JERSEY AVENUE NW Ste 900","city":"Washington","state":"DC","zip":"20001","name":"ALLIANCE FOR CELL THERAPY FOUNDATION","address":"300 NEW JERSEY AVENUE NW Ste 900, Washington, DC, 20001"}],"transaction_flags":{"dividends_from_related_organization_indicator":false,"gift_grant_or_capital_contribution_from_other_org":false,"gift_grant_or_capital_contribution_to_other_org":false,"loans_or_guarantees_from_other_org":false,"loans_or_guarantees_to_other_org":false,"performance_of_services_by_other_orgs":false,"performance_of_services_for_other_orgs":false,"sharing_of_facilities":false,"sharing_of_paid_employees":false,"reimbursement_paid_by_other_org":false,"reimbursement_paid_to_other_org":false,"rental_of_facilities_from_other_orgs":false,"rental_of_facilities_to_other_orgs":false,"purchase_of_assets_from_other_org":false,"sale_of_assets_to_other_org":false,"exchange_of_assets":false,"receipt_of_interest_annuities_rents_royalties":false,"other_transfer_from_other_org":false,"other_transfer_to_other_org":false}},"source_xml":"202333139349303268_public.xml"},{"Organization":{"Hours":[0],"Total Compensation":[0],"Direct compensation":[0],"Other compensation":[0]},"Basic":{"mission":"Advance the availability of safe and effective regenerative cell therapies for patients in need.","primary_activities":"Other office expenses $12.00\n\nInformation technology $300.00\n\nOther $235.00\n\nCompliance consulting $529.00\n\nAdvance the availability of safe and effective regenerative\n\nCell therapies for patients in need.\n\n1. In support of its goal to advance therapies to support patients in\n\nNeed, the organization convened an advisory group comprised of\n\nScientists, researchers, clinical experts, and patients to guide the\n\nDevelopment of policy actions needed to advance the field.\n\n2. In support of its goal to advance therapies to support patients in\n\nNeed through education and advocacy, the organization developed white\n\nPapers, briefs, and other communications materials raise awareness of\n\nThe current state of the field, barriers to progress, and policy\n\nActions needed.\n\n3. In support of its goal to advance therapies to support patients in\n\nNeed,the organization assessed the federal government's progress\n\nAgainst legislative requirements and other federal policies.\n\n4. In support of its goal to advance therapies to support patients in\n\nNeed, the organization successfully advocated for public policy to\n\nEncourage greater investment in clinical trials, the characterization,\n\nOptimization and scaling of manufacturing, and collaborative\n\nEvidence development and transparency related to such therapies.\n\n5. In support of its goal to advance therapies to support patients in\n\nNeed, the organization developed and advocated for a policy proposal\n\nFor modernizing the regulatory framework for cell therapies.\n\n6. In support of its goal to advance therapies to support patients in\n\nNeed, the organization advocated for funding for a center for\n\nInnovation in cell and gene therapy to support academic medical\n\nCenters and small biotechs with early stage clinical trials, manufacturing\n\nAnd navigating regulatory evaluation and approval of cell therapies.","year":2024,"name":"Alliance for Cell Therapy Now","phone":"2029229077","website":"www.allianceforcelltherapynow.org","type":"990EZ","tax_period_begin":"2024-01-01T00:00:00","tax_period_end":"2024-12-31T00:00:00","address":"10332 Main Street STE 345, Fairfax, VA, 22030, USA","city":"Fairfax","state":"VA","country":"USA","zip_code":"22030"},"Governance":{"501c determination":true},"Revenues":{"value":10,"Contributions":{"value":10,"Contributions from gifts and grants":10}},"Expenses":{"value":1826,"Total professional fundraising expense":{"value":1279,"Fees to independent contractors":1279},"Other expenses":{"value":547,"Itemized Expenses":547},"Functional Expenses":{"Program Service Expenses":300}},"Assets":{"value":3174,"Savings and temp cash investments":1174,"Land, building, equipment":0,"Other assets":2000},"Liabilities":{"value":1103,"Sum of Total Liabilities":1103},"Fund balance":{"value":2071},"Form990Details":{"officers_directors_key_employees":[{"person_name":"JANET MARCHIBRODA","title":"DirectorChairman","average_hours_per_week_devoted_to_position":0.5,"compensation":0,"employee_benefit_contributions":0,"expense_account_allowances":0,"name":"JANET MARCHIBRODA"},{"person_name":"MICHELE REISNER","title":"TREASURER","average_hours_per_week_devoted_to_position":0.5,"compensation":0,"employee_benefit_contributions":0,"expense_account_allowances":0,"name":"MICHELE REISNER"}]},"ScheduleB":{"attached":false},"source_xml":"202503149349200835_public.xml"},{"Organization":{"Hours":[0],"Total Compensation":[0],"Direct compensation":[0],"Other compensation":[0]},"Basic":{"mission":"Advance the availability of safe and effective regenerative cell therapies for patients in need","primary_activities":"1.In support of its goal to advance therapies to support patients in need, the organization convened an advisory group comprised of scientists, researchers, clinical experts, and patients to guide the development of policy actions needed to advance the field. 2.In support of its goal to advance therapies to support patients in need through education and advocacy, the organization developed white papers, briefs, and other communications materials raise aware awareness of the current state of the field, barriers to progress, and policy actions needed. 3. In support of its goal to advance therapies to support patients in need, the organization assessed the federal government's progress","year":2023,"name":"Alliance for Cell Therapy Now","phone":"2029229077","website":"www.allianceforcelltherapynow.org","type":"990","principal_officer":"JANET MARCHIBRODA","year_formation":2015,"state_legal_domicile":"DC","tax_period_begin":"2023-01-01T00:00:00","tax_period_end":"2023-12-31T00:00:00","address":"300 New Jersey Avenue NW Ste 900, Washington, DC, 20001, USA","city":"Washington","state":"DC","country":"USA","zip_code":"20001"},"Governance":{"501c determination":true,"Number of voting members":3,"Number of independent voting members":3,"Number of employees total":0,"Total Gross UBI":0,"Number of employees":0,"Prohibited tax shelter transactions":false,"Taxable party notification":false,"Family or business relationship":false,"Delegation of management duties":false,"Conflict of interest policy":true,"Whistle blower policy":true,"Compensation process for CEO":false,"Compensation process for other employees":false,"Changes to organizing documents":false,"Material diversion or misuse":false,"Members or stockholders":false,"Election of board members":false,"Decisions subject to approval":false,"Minutes of governing body":true,"Local chapters":false,"Form 990 provided to governing body":false,"Document retention policy":true,"Investment in joint venture":false,"Independent audit financial statements":false,"Consolidated audit financial statements":false,"Accountant compile or review":false,"Financial statements audited by independent accountant":false,"Federal grant audit required":false,"Political activities":false,"Donor advised funds":false,"Conservation easements":false,"Collections of art":false,"School":false,"Hospital":false,"Foreign activities":false,"Foreign office":false,"Gaming":false,"Fundraising activities":false,"Professional fundraising":false,"Loan to officer or DQP":false,"Grant to related person":false,"Business relationship through family member":false,"Business relationship with organization":false},"Revenues":{"value":0,"Contributions":{"value":0},"Program revenue":{"value":0},"Investment income":{"value":0},"Other revenues":{"value":0,"Net income from fundraising events":0}},"Expenses":{"value":16004,"Grant expense":{"value":0},"Total professional fundraising expense":{"value":0},"Benefits paid to members":{"value":0},"Salaries":{"value":0},"Other expenses":{"value":16004,"Legal":855,"Accounting":1350,"Other services":1826,"Office expenses":693,"Information technology":6932,"Occupancy":4348},"Functional Expenses":{"Program Service Expenses":6970,"Management And General Expenses":9034,"Fundraising Expenses":0}},"Assets":{"value":15189,"Non-interest bearing cash":15189},"Liabilities":{"value":11302,"Accounts payable, accrued":11302},"Fund balance":{"value":3887},"Form990Details":{"program_service_accomplishments":[{"description":"1.In support of its goal to advance therapies to support patients in need, the organization convened an advisory group comprised of scientists, researchers, clinical experts, and patients to guide the development of policy actions needed to advance the field. 2.In support of its goal to advance therapies to support patients in need through education and advocacy, the organization developed white papers, briefs, and other communications materials raise aware awareness of the current state of the field, barriers to progress, and policy actions needed. 3. In support of its goal to advance therapies to support patients in need, the organization assessed the federal government's progress","expense":6970}],"functional_expense_allocations":{"legal_fees":{"management_and_general":855,"total":855},"accounting_fees":{"management_and_general":1350,"total":1350},"other_service_fees":{"management_and_general":1826,"total":1826},"office_expenses":{"program_services":38,"management_and_general":655,"total":693},"information_technology":{"program_services":6932,"total":6932},"occupancy":{"total":4348}},"tax_and_disclosure_flags":{"activities_conducted_through_partnership":false,"foreign_financial_account":false,"backup_withholding_compliance":true,"lobbying_activities":false,"deductible_non_cash_contributions":false,"deductible_contributions_of_art":false,"donor_restricted_or_quasi_endowments":false,"method_of_accounting_accrual":true,"schedule_o_part_vi":true,"schedule_o_part_ix":true},"principal_officer_detail":{"person_name":"JANET MARCHIBRODA"},"audit_financial_statement_detail":{"accountant_compile_or_review":false,"federal_grant_audit_required":false},"related_party_due_diligence":{"business_relationship_with_35_controlled_entity":false,"officer_mailing_address":false,"related_entity":true,"related_org_controlled_entity":false,"compensation_from_other_sources":false,"excess_benefit_transaction":false,"annual_disclosure_covered_persons":true},"grant_due_diligence":{"grants_to_organizations":false,"grants_to_individuals":false,"more_than_5000_to_organizations":false,"more_than_5000_to_individuals":false},"books_in_care_of_detail":{"phone":"2055334260","business_name_line1":"Crosby Ottenhoff Group","address_line1":"611 PENNSYLVANIA AVE SE Ste 267","city":"Washington","state":"DC","zip":"20003"},"officers_directors_key_employees":[{"person_name":"JOANNE KURTZBERG","title":"DIRECTOR","reportable_comp_from_org":0,"reportable_comp_from_related_orgs":0,"other_compensation":0,"individual_trustee_or_director":true,"name":"JOANNE KURTZBERG"},{"person_name":"FRED SANFILIPPO","title":"DIRECTORCHAIRMAN","reportable_comp_from_org":0,"reportable_comp_from_related_orgs":0,"other_compensation":0,"individual_trustee_or_director":true,"officer":true,"name":"FRED SANFILIPPO"},{"person_name":"JANET MARCHIBRODA","title":"PRESIDENTSECRETARY","reportable_comp_from_org":0,"reportable_comp_from_related_orgs":0,"other_compensation":0,"individual_trustee_or_director":true,"officer":true,"name":"JANET MARCHIBRODA"},{"person_name":"MICHELE REISNER","title":"TREASURER","reportable_comp_from_org":0,"reportable_comp_from_related_orgs":0,"other_compensation":0,"officer":true,"name":"MICHELE REISNER"}]},"ScheduleB":{"attached":false,"required":false},"ScheduleR":{"tax_exempt_organizations":[{"ein":861221438,"business_name_line1":"ALLIANCE FOR CELL THERAPY FOUNDATION","primary_activities_text":"Education","exempt_code_section_text":"501 c3","public_charity_status_text":"170b1Avi","controlled_organization_indicator":false,"legal_domicile_state":"DC","address_line1":"300 NEW JERSEY AVENUE NW Ste 900","city":"Washington","state":"DC","zip":"20001","name":"ALLIANCE FOR CELL THERAPY FOUNDATION","address":"300 NEW JERSEY AVENUE NW Ste 900, Washington, DC, 20001"}],"transaction_flags":{"dividends_from_related_organization_indicator":false,"gift_grant_or_capital_contribution_from_other_org":false,"gift_grant_or_capital_contribution_to_other_org":false,"loans_or_guarantees_from_other_org":false,"loans_or_guarantees_to_other_org":false,"performance_of_services_by_other_orgs":false,"performance_of_services_for_other_orgs":false,"sharing_of_facilities":false,"sharing_of_paid_employees":false,"reimbursement_paid_by_other_org":false,"reimbursement_paid_to_other_org":false,"rental_of_facilities_from_other_orgs":false,"rental_of_facilities_to_other_orgs":false,"purchase_of_assets_from_other_org":false,"sale_of_assets_to_other_org":false,"exchange_of_assets":false,"receipt_of_interest_annuities_rents_royalties":false,"other_transfer_from_other_org":false,"other_transfer_to_other_org":false}},"source_xml":"202403139349304395_public.xml"}],"Latest":{"Organization":{"Hours":[0],"Total Compensation":[0],"Direct compensation":[0],"Other compensation":[0]},"Basic":{"mission":"Advance the availability of safe and effective regenerative cell therapies for patients in need.","primary_activities":"Other office expenses $12.00\n\nInformation technology $300.00\n\nOther $235.00\n\nCompliance consulting $529.00\n\nAdvance the availability of safe and effective regenerative\n\nCell therapies for patients in need.\n\n1. In support of its goal to advance therapies to support patients in\n\nNeed, the organization convened an advisory group comprised of\n\nScientists, researchers, clinical experts, and patients to guide the\n\nDevelopment of policy actions needed to advance the field.\n\n2. In support of its goal to advance therapies to support patients in\n\nNeed through education and advocacy, the organization developed white\n\nPapers, briefs, and other communications materials raise awareness of\n\nThe current state of the field, barriers to progress, and policy\n\nActions needed.\n\n3. In support of its goal to advance therapies to support patients in\n\nNeed,the organization assessed the federal government's progress\n\nAgainst legislative requirements and other federal policies.\n\n4. In support of its goal to advance therapies to support patients in\n\nNeed, the organization successfully advocated for public policy to\n\nEncourage greater investment in clinical trials, the characterization,\n\nOptimization and scaling of manufacturing, and collaborative\n\nEvidence development and transparency related to such therapies.\n\n5. In support of its goal to advance therapies to support patients in\n\nNeed, the organization developed and advocated for a policy proposal\n\nFor modernizing the regulatory framework for cell therapies.\n\n6. In support of its goal to advance therapies to support patients in\n\nNeed, the organization advocated for funding for a center for\n\nInnovation in cell and gene therapy to support academic medical\n\nCenters and small biotechs with early stage clinical trials, manufacturing\n\nAnd navigating regulatory evaluation and approval of cell therapies.","year":2024,"name":"Alliance for Cell Therapy Now","phone":"2029229077","website":"www.allianceforcelltherapynow.org","type":"990EZ","tax_period_begin":"2024-01-01T00:00:00","tax_period_end":"2024-12-31T00:00:00","address":"10332 Main Street STE 345, Fairfax, VA, 22030, USA","city":"Fairfax","state":"VA","country":"USA","zip_code":"22030"},"Governance":{"501c determination":true},"Revenues":{"value":10,"Contributions":{"value":10,"Contributions from gifts and grants":10}},"Expenses":{"value":1826,"Total professional fundraising expense":{"value":1279,"Fees to independent contractors":1279},"Other expenses":{"value":547,"Itemized Expenses":547},"Functional Expenses":{"Program Service Expenses":300}},"Assets":{"value":3174,"Savings and temp cash investments":1174,"Land, building, equipment":0,"Other assets":2000},"Liabilities":{"value":1103,"Sum of Total Liabilities":1103},"Fund balance":{"value":2071},"Form990Details":{"officers_directors_key_employees":[{"person_name":"JANET MARCHIBRODA","title":"DirectorChairman","average_hours_per_week_devoted_to_position":0.5,"compensation":0,"employee_benefit_contributions":0,"expense_account_allowances":0,"name":"JANET MARCHIBRODA"},{"person_name":"MICHELE REISNER","title":"TREASURER","average_hours_per_week_devoted_to_position":0.5,"compensation":0,"employee_benefit_contributions":0,"expense_account_allowances":0,"name":"MICHELE REISNER"}]},"ScheduleB":{"attached":false},"Ratings":{"Mission Deployment Rate":{"score":1.0730436273249335},"Program Expense Ratio":{"score":0.16429353778751368},"Fundraising Efficiency":{"score":null,"percentile":null},"Filing Consistency Score":{"score":0.8888888888888888},"Grant Itemization Coverage":{"score":null},"Independent Voting Board Pct":{"score":null},"Operating Margin":{"score":-181.6,"percentile":0.006096738332685749},"Operating Reserve Ratio":{"score":1.7382256297918948,"percentile":0.6076739936880572},"Liabilities to Assets Ratio":{"score":0.3475110270951481,"percentile":0.19306892702664993},"Officer Compensation Ratio":{"score":null,"percentile":null},"Program Expense Growth":{"score":-1.46976643875008,"percentile":0.0029168500276451938},"Revenue Growth":{"score":-1.4999142881631953,"percentile":0.0013860280670683581},"Asset Growth":{"score":-1.130823819808701,"percentile":0.0025813146970731964},"Foreign Oversight Score":{"score":null},"Major-Donor Itemization":{"score":null},"Related-Party Transparency":{"score":null},"Pay-Setting Controls":{"score":1.0,"weight":5,"atoms":{"Compensation committee":{"value":true},"Independent compensation consultant":{"value":true},"Form 990 of other organizations reviewed":{"value":true},"Written employment contract":{"value":true},"Compensation survey or study":{"value":true},"Board or committee approval":{"value":true}}},"Governance Policy Score":{"score":null,"weight":5,"atoms":{"Conflict of interest policy":{"value":null},"Whistle blower policy":{"value":null},"Document retention policy":{"value":null},"Compensation process for CEO":{"value":null},"Compensation process for other employees":{"value":null},"Form 990 provided to governing body":{"value":null},"Minutes of governing body":{"value":null},"Audit committee":{"value":null},"Independent audit financial statements":{"value":null}}},"Categories":{"Financial Efficiency":{"score":0.7783138685560406,"weight":45},"Transparency & Controls":{"score":0.9285714285714286,"weight":20},"Accountability":{"score":null,"weight":14},"Sustainability":{"score":0.23155211527700478,"weight":13},"Growth":{"score":0.00223741417730006,"weight":8}},"Overall Score":{"score":0.6584142961449984,"percentile":0.24382446338307992}},"source_xml":"202503149349200835_public.xml"},"sector":"","donation_categories":[],"zakat_policy":null},"error":null}